Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered?
Aims: To assess variations in dementia treatment, diagnosis, and pathway practices across the memory services in Tees, Esk and Wear Valleys (TEWV) NHS Foundation Trust and how these compare to Trust and national policy. There were reports that the dementia diagnostic process across the trust was inc...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-06-01
|
| Series: | BJPsych Open |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425105528/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849316380966387712 |
|---|---|
| author | Olusegun Sodiya Oluwatosin Atewogboye Roseline Ataria Mani Krishnan Rachael Raw |
| author_facet | Olusegun Sodiya Oluwatosin Atewogboye Roseline Ataria Mani Krishnan Rachael Raw |
| author_sort | Olusegun Sodiya |
| collection | DOAJ |
| description | Aims: To assess variations in dementia treatment, diagnosis, and pathway practices across the memory services in Tees, Esk and Wear Valleys (TEWV) NHS Foundation Trust and how these compare to Trust and national policy. There were reports that the dementia diagnostic process across the trust was inconsistent. Thus, it was important to find out if the diagnostic pathway differed. NICE guidelines NG97 (2018) recommended neuroimaging, cognitive testing, and history to make diagnosis and the use of validated criteria to diagnose dementia subtypes. NG97 (2018) and TEWV Dementia Pathway suggested use of cholinesterase inhibitors to those with Alzheimer’s disease, mixed dementia, dementia with Lewy bodies and Parkinson’s disease dementia. These guidelines mentioned that memantine should be offered to those with severe Alzheimer’s, or those with moderate Alzheimer’s disease with a contraindication to cholinesterase inhibitors. |
| format | Article |
| id | doaj-art-572a7b8f16cd4e379cb98030979bf329 |
| institution | Kabale University |
| issn | 2056-4724 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | BJPsych Open |
| spelling | doaj-art-572a7b8f16cd4e379cb98030979bf3292025-08-20T03:51:44ZengCambridge University PressBJPsych Open2056-47242025-06-0111S218S21910.1192/bjo.2025.10552Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered?Olusegun Sodiya0Oluwatosin Atewogboye1Roseline Ataria2Mani Krishnan3Rachael Raw4Tees,Esk and Wear Valleys NHS Foundation Trust, Stockton, United KingdomCumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle, United KingdomTees,Esk and Wear Valleys NHS Foundation Trust, Stockton, United KingdomTees,Esk and Wear Valleys NHS Foundation Trust, Stockton, United KingdomTees,Esk and Wear Valleys NHS Foundation Trust, Stockton, United KingdomAims: To assess variations in dementia treatment, diagnosis, and pathway practices across the memory services in Tees, Esk and Wear Valleys (TEWV) NHS Foundation Trust and how these compare to Trust and national policy. There were reports that the dementia diagnostic process across the trust was inconsistent. Thus, it was important to find out if the diagnostic pathway differed. NICE guidelines NG97 (2018) recommended neuroimaging, cognitive testing, and history to make diagnosis and the use of validated criteria to diagnose dementia subtypes. NG97 (2018) and TEWV Dementia Pathway suggested use of cholinesterase inhibitors to those with Alzheimer’s disease, mixed dementia, dementia with Lewy bodies and Parkinson’s disease dementia. These guidelines mentioned that memantine should be offered to those with severe Alzheimer’s, or those with moderate Alzheimer’s disease with a contraindication to cholinesterase inhibitors.https://www.cambridge.org/core/product/identifier/S2056472425105528/type/journal_article |
| spellingShingle | Olusegun Sodiya Oluwatosin Atewogboye Roseline Ataria Mani Krishnan Rachael Raw Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered? BJPsych Open |
| title | Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered? |
| title_full | Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered? |
| title_fullStr | Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered? |
| title_full_unstemmed | Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered? |
| title_short | Trustwide Clinical Audit of Dementia Diagnosis: How Are Diagnoses Made and What Treatments Are Offered? |
| title_sort | trustwide clinical audit of dementia diagnosis how are diagnoses made and what treatments are offered |
| url | https://www.cambridge.org/core/product/identifier/S2056472425105528/type/journal_article |
| work_keys_str_mv | AT olusegunsodiya trustwideclinicalauditofdementiadiagnosishowarediagnosesmadeandwhattreatmentsareoffered AT oluwatosinatewogboye trustwideclinicalauditofdementiadiagnosishowarediagnosesmadeandwhattreatmentsareoffered AT roselineataria trustwideclinicalauditofdementiadiagnosishowarediagnosesmadeandwhattreatmentsareoffered AT manikrishnan trustwideclinicalauditofdementiadiagnosishowarediagnosesmadeandwhattreatmentsareoffered AT rachaelraw trustwideclinicalauditofdementiadiagnosishowarediagnosesmadeandwhattreatmentsareoffered |